202 related articles for article (PubMed ID: 28093700)
1. Postdiagnostic use of β-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person-years of follow-up.
Kim SA; Moon H; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Clin Transl Oncol; 2017 Jul; 19(7):826-833. PubMed ID: 28093700
[TBL] [Abstract][Full Text] [Related]
2. Aspirin use and head and neck cancer survival: an observational study of 11,623 person-years follow-up.
Kim SA; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Int J Clin Oncol; 2018 Feb; 23(1):52-58. PubMed ID: 28725937
[TBL] [Abstract][Full Text] [Related]
3. Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer.
Kwon M; Roh JL; Song J; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Ann Oncol; 2014 Jun; 25(6):1208-14. PubMed ID: 24669018
[TBL] [Abstract][Full Text] [Related]
4. Effect of β-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death.
De Giorgi V; Gandini S; Grazzini M; Benemei S; Marchionni N; Geppetti P
Mayo Clin Proc; 2013 Nov; 88(11):1196-203. PubMed ID: 24182700
[TBL] [Abstract][Full Text] [Related]
5. Second Primary Head and Neck Cancers After Non-Head and Neck Primary Cancers.
Schlieve T; Heidel RE; Carlson ER
J Oral Maxillofac Surg; 2016 Dec; 74(12):2515-2520. PubMed ID: 27292523
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for long-term survival in head and neck squamous cell carcinoma patients with distant metastasis after initial definitive treatment.
Kang HS; Roh JL; Kim MJ; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
J Cancer Res Clin Oncol; 2016 Jan; 142(1):295-304. PubMed ID: 26341665
[TBL] [Abstract][Full Text] [Related]
7. Survival After Distant Metastasis in Head and Neck Cancer.
Wiegand S; Zimmermann A; Wilhelm T; Werner JA
Anticancer Res; 2015 Oct; 35(10):5499-502. PubMed ID: 26408715
[TBL] [Abstract][Full Text] [Related]
8. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
Jung YS; Lim J; Jung KW; Ryu J; Won YJ
PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
[TBL] [Abstract][Full Text] [Related]
9. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
[TBL] [Abstract][Full Text] [Related]
10. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.
Shin DM; Lee JS; Lippman SM; Lee JJ; Tu ZN; Choi G; Heyne K; Shin HJ; Ro JY; Goepfert H; Hong WK; Hittelman WN
J Natl Cancer Inst; 1996 Apr; 88(8):519-29. PubMed ID: 8606380
[TBL] [Abstract][Full Text] [Related]
11. Noncancer-Related Health Events and Mortality in Head and Neck Cancer Patients After Definitive Radiotherapy: A Prospective Study.
Kang HS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Medicine (Baltimore); 2016 May; 95(19):e3403. PubMed ID: 27175640
[TBL] [Abstract][Full Text] [Related]
12. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma.
Papagerakis S; Bellile E; Peterson LA; Pliakas M; Balaskas K; Selman S; Hanauer D; Taylor JM; Duffy S; Wolf G
Cancer Prev Res (Phila); 2014 Dec; 7(12):1258-69. PubMed ID: 25468899
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence-free survival.
Kyrgidis A; Tzellos TG; Kechagias N; Patrikidou A; Xirou P; Kitikidou K; Bourlidou E; Vahtsevanos K; Antoniades K
Eur J Cancer; 2010 Jun; 46(9):1563-72. PubMed ID: 20338745
[TBL] [Abstract][Full Text] [Related]
15. Effect of metformin on progression of head and neck cancers, occurrence of second primary cancers, and cause-specific survival.
Kwon M; Roh JL; Song J; Lee SW; Kim SB; Choi SH; Nam SY
Oncologist; 2015 May; 20(5):546-53. PubMed ID: 25802404
[TBL] [Abstract][Full Text] [Related]
16. Second primary lung cancers following a diagnosis of primary head and neck cancer.
Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S
Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386
[TBL] [Abstract][Full Text] [Related]
17. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases.
Rennemo E; Zätterström U; Boysen M
Laryngoscope; 2008 Aug; 118(8):1350-6. PubMed ID: 18496157
[TBL] [Abstract][Full Text] [Related]
18. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
[TBL] [Abstract][Full Text] [Related]
19. The Role of Beta-Blockers in the Treatment of Hypertension.
Cruickshank JM
Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
[TBL] [Abstract][Full Text] [Related]
20. Selection of Ideal Candidates for Surgical Salvage of Head and Neck Squamous Cell Carcinoma: Effect of the Charlson-Age Comorbidity Index and Oncologic Characteristics on 1-Year Survival and Hospital Course.
Kim J; Kim S; Albergotti WG; Choi PA; Kaplan DJ; Abberbock S; Johnson JT; Gildener-Leapman N
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1059-65. PubMed ID: 26447790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]